Lewy Body Dementia Symptoms That Differ From Alzheimer’s

The four symptoms that separate Lewy body dementia from Alzheimer's, why memory testing misses it, and the drug class that makes the distinction urgent.

Lewy body dementia announces itself through attention, vision, sleep and movement rather than memory. The four features that separate it from Alzheimer's disease are fluctuating cognition and alertness, recurrent well-formed visual hallucinations, REM sleep behavior disorder, and spontaneous parkinsonism — and none of these are typical of early Alzheimer's, where gradual memory loss comes first.

Dementia with Lewy bodies (DLB) is caused by deposits of a protein called alpha-synuclein in brain cells. It is now considered a leading cause of degenerative dementia after Alzheimer's, accounting for roughly 20–34% of dementia cases according to a primary-care review of DLB, and it is most often misdiagnosed as Alzheimer's disease, Parkinson's disease, or a psychiatric illness. Getting the distinction right changes which medications are safe.

Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.

Table of Contents

The four core features that point to Lewy body dementia

The 2017 fourth consensus criteria from the DLB Consortium, published in *Neurology*, define the core clinical features that distinguish DLB from Alzheimer's: The 2017 revision made two notable changes. It promoted REM sleep behavior disorder from a "suggestive" feature to a core clinical feature, and it moved antipsychotic hypersensitivity down to a supportive feature. RBD matters so much because it can appear years, sometimes decades, before any cognitive decline — making it the earliest usable signal many families have.

  • **Fluctuating cognition and attention** — good hours and bad hours in the same day, with episodes of staring, blankness or disorganized speech. Alzheimer's decline is comparatively steady.
  • **Recurrent visual hallucinations** that are well formed and detailed, often people, children or animals, and often not frightening to the person seeing them.
  • **REM sleep behavior disorder (RBD)** — physically acting out dreams: shouting, punching, kicking or falling out of bed while asleep.
  • **Spontaneous parkinsonism** — at least one cardinal motor sign appearing with or before the dementia.

Why movement symptoms arrive early here and late in Alzheimer's

The parkinsonism criterion is specific. The 2017 criteria require at least one spontaneous cardinal motor sign: bradykinesia (slowness of movement, with a decrement in the amplitude or speed of repeated movements), rest tremor, or rigidity. "Spontaneous" means it is not caused by medication. The timing is the discriminator.

In DLB these signs appear alongside or before the dementia; in Alzheimer's disease, motor signs typically appear only in late stages. So a person who develops a shuffling gait, stiffness or stooped posture in the same year as their thinking changes is not showing a typical Alzheimer's pattern. One sign is enough to meet the criterion, but one sign is not a diagnosis. Falls, stiffness and slowness have many causes, and drug-induced parkinsonism from antipsychotics or anti-nausea medication is specifically excluded.

Memory is often the wrong thing to test for

Standard dementia screening is built around memory, which is exactly why early DLB slips through. A neuropsychological comparison of the two conditions found DLB patients perform worse than Alzheimer's patients on attention, visuospatial and executive tasks, while scoring *better* on memory measures. Drawing and copying tasks are the most practical discriminator. A review of the Lewy body dementias reports that visuospatial or constructional impairment was present in 74% of patients with early-stage, autopsy-confirmed DLB, compared with 45% of those with Alzheimer's disease.

Copying a cube or a pentagon, or drawing a clock face, exposes this in minutes. The same review notes a second asymmetry: delayed recognition memory is relatively spared in pure Lewy body disease compared with pure Alzheimer's or mixed pathology, even when free recall looks similar. In plain terms, someone with DLB often recognizes the right answer when given choices or cues — a cueing benefit Alzheimer's patients typically do not show. If a clinic visit covers only word-list recall and orientation questions, ask whether visuospatial and attention testing was done.

The medication warning that makes the distinction urgent

Antipsychotic hypersensitivity is the reason this is not an academic question. The Lewy Body Dementia Association warns that up to 50% of people with LBD who are given any antipsychotic may develop severe neuroleptic sensitivity — worsening rigidity, heavy sedation, confusion and autonomic collapse. Mayo Clinic advises against using these drugs in Lewy body dementia.

This is also where misdiagnosis does its damage. Because hallucinations and delusions can arrive before obvious dementia, DLB is often read as a primary psychiatric illness, and an antipsychotic is the standard response to psychosis. The person is then exposed to a drug class their brain tolerates badly. Practical steps for families:.

  • Tell every new clinician, dentist, surgeon and emergency department that Lewy body dementia is suspected or diagnosed.
  • Ask specifically whether any newly prescribed drug is an antipsychotic or has antipsychotic activity, including some anti-nausea medicines.
  • Carry a written note or wallet card stating the diagnosis and the hypersensitivity risk.
  • Raise non-drug approaches first for hallucinations that are not distressing — many people with DLB find them tolerable once they understand what they are.

How many symptoms it takes for a diagnosis

Under the 2017 criteria, **probable DLB** requires two or more core clinical features, or one core feature plus at least one indicative biomarker. A single core feature on its own yields only **possible DLB**. Hallucinations alone, or dream enactment alone, does not establish the diagnosis.

The indicative biomarkers are the second route. They include reduced dopamine transporter uptake on SPECT or PET imaging, abnormal MIBG cardiac scintigraphy, and polysomnography confirming REM sleep without atonia — the sleep study finding that objectively documents RBD. Tracking what you observe makes the appointment more useful than describing it from memory. Note the time of day when confusion is worst, how often fluctuations happen, what the hallucinations look like, and when the dream-enacting behavior started — a bed partner is often the only person who knows.

Where the clinical picture reaches its limit

Clinical criteria validated against autopsy findings show high specificity but variable sensitivity, meaning a positive clinical diagnosis is usually right while a negative one misses cases. The 2017 criteria and the Alzheimer's Association both note that Lewy body pathology coexists with Alzheimer's pathology in a large share of late-onset cases, so a definitive separation remains pathological rather than clinical. That overlap has a practical consequence: mixed pathology means a person can genuinely have both diseases, and the symptom picture will not sort neatly into one column.

A diagnosis of DLB does not rule out Alzheimer's changes, and a diagnosis of Alzheimer's does not mean the antipsychotic warning can be ignored when core DLB features are present. So treat the four core features as a reason to change what gets tested and what gets prescribed, not as a verdict. If someone has been labeled with Alzheimer's disease but acts out dreams, sees detailed figures, swings between lucid and absent within a day, or moves stiffly, that is the specific case to bring back to a neurologist — ideally one who sees Lewy body disease regularly.

Frequently Asked Questions

Can REM sleep behavior disorder appear before any memory or thinking problems?

Yes. The 2017 DLB Consortium criteria note that acting out dreams can begin years, and sometimes decades, before cognitive decline, which is part of why it was promoted to a core clinical feature.

Are the visual hallucinations in Lewy body dementia frightening?

Not necessarily. The criteria describe them as recurrent and well formed — detailed people, children or animals — and many people experience them without distress once they know what is happening.

Does a shuffling gait or tremor mean Lewy body dementia rather than Alzheimer's?

Not by itself. The motor sign must be spontaneous rather than drug-induced, and probable DLB requires two core features or one plus an indicative biomarker, so a single motor sign yields only possible DLB.

Is there a scan that can confirm it?

Imaging and sleep studies can support the diagnosis as indicative biomarkers — dopamine transporter SPECT or PET, MIBG cardiac scintigraphy, and polysomnography showing REM sleep without atonia — but a definitive separation from Alzheimer's is still made pathologically.


You Might Also Like

HelpDementia.com

Dementia, Alzheimer's, Caregiving & Healthy Aging Guidance

© 2026 HelpDementia.com. All rights reserved.

Educational information only. It is not medical advice and does not replace care from a qualified clinician.